The PROXIDRUGS consortium actively took part in the EMBO Workshop “Cancer cell signaling: Linking molecular knowledge on cancer therapy”...

In a press release issued by Fraunhofer Society, the PROXIDRUGS consortium is introduced to the broad public. PROXIDRUGS project leader...

A oncology project from Goethe University was now chosen for funding within the beLAB2122 BRIDGE partnership. On the academic side, the...

The German Chemical Biology Lectureship is awarded by the Joint Working Group Chemical Biology to outstanding young scientists to honor...

PROXIDRUGS speaker Ivan Đikić has been awarded with an Advanced Grant of the European Research Council (ERC). This is the third time he...

InnoTECH scientist Manuel Kaulich was appointed as FCI professor for autophagy in tumor pathogenesis as part of the LOEWE Center...

Ivan Đikić, Aimo Kannt and Kerstin Koch, all members of the PROXIDRUGS consortium, s hare their views on how strategic collaboration has...

Neurological complications associated with COVID-19 have been observed frequently. Although SARS-CoV-2 may be abundant in brain tissue of...

In the latest issue of Current Research in Chemical Biology, PROXIDRUGS project leader Felix Hausch and collegues from TU Darmstadt...

Christian Münch, PROXIDRUGS project leader at the Institute of Biochemistry II of Goethe University Frankfurt, was selected as an EMBO...